Keeping up with the science: Innovation in the health and care system post Brexit
Article
Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.
However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.
Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.
Related items

The British business investment visa: A new model for investment migration in the UK
We recommend a new approach to investment migration in the UK focussed on maximising economic benefits and minimising the risks of abuse.
"Primary is what comes first": How end of key stage 2 exams impact disadvantaged children
End of primary school tests need reform to work better for the children who need the most support at school.
The Europe agenda: Our values
Why we must redesign our relationship with Europe around the values we share and want to defend.